Akazawa, Manabu; Stempel, David A. - In: PharmacoEconomics 24 (2006) 10, pp. 971-988
Clinical studies have shown that the combination of an inhaled corticosteroid (ICS) and a long-acting beta2-adrenoceptor agonist (LABA) for patients with asthma is more effective than the use of ICS alone in equivalent or higher doses, as well as the use of other combinations. However, the...